NT-proBNP Levels During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.

Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)

NCT00139932 ·Status: COMPLETED ·Phase: PHASE4

Beta Blocker Therapy in Moderate to Severe COPD

NCT01656005 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

NCT03590379 ·Status: COMPLETED ·Phase: PHASE2

SERETIDE Plus Tiotropium Versus Individual Components

NCT00325169 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD

NCT01917331 ·Status: COMPLETED ·Phase: PHASE3

Formoterol Via pMDI HFA-134a Propellant or DPI in Partially Reversible Chronic Obstructive Pulmonary Disease (COPD)

NCT00742248 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers

NCT01398111 ·Status: COMPLETED ·Phase: PHASE1

Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease

NCT03566667 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Symbicort in Chronic Obstruktive Pulmonary Disease

NCT00612976 ·Status: COMPLETED

Preventing Adverse Cardiac Events in COPD

NCT03917914 ·Status: COMPLETED ·Phase: PHASE3

PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)

NCT05652439 ·Status: RECRUITING

BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)

NCT00929851 ·Status: COMPLETED ·Phase: PHASE3

Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients

NCT02975843 ·Status: COMPLETED ·Phase: PHASE1

Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00783250 ·Status: TERMINATED ·Phase: PHASE4

A Comparative Effectiveness Study of Mortality Outcomes and Related Cardiopulmonary Events Among a Cohort of Chronic Obstructive Pulmonary Disease (COPD) Patients Who Initiate Breztri and Multiple Inhaler Triple Therapy (MITT) in the United States (US)

NCT06744374 ·Status: COMPLETED

Budesonide / Formoterol in Treatment of Exacerbations of COPD

NCT00239278 ·Status: COMPLETED ·Phase: PHASE2

Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPD

NCT03258749 ·Status: UNKNOWN ·Phase: NA

A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

NCT01691482 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

NCT01176903 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Three Treatment of Chronic Obstructive Pulmonary Disease Patients

NCT04520230 ·Status: COMPLETED ·Phase: PHASE4

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

NCT04320342 ·Status: COMPLETED ·Phase: PHASE3

Comparison Between Symbicort® and Prednisolone in COPD

NCT00259779 ·Status: COMPLETED ·Phase: PHASE3

Change in Symptom and Quality of Life in COPD by Budesonide/Glycopyrronium/Formoterol Fumarate Pressurized Metered Dose Inhaler (BGF pMDI)

NCT05219630 ·Status: COMPLETED

Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01613326 ·Status: COMPLETED ·Phase: PHASE3

Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF]

NCT06511193 ·Status: ACTIVE_NOT_RECRUITING